Inside the Single-Cell Revolution: One Biosciences’ Path to Clinical Reality
In this episode of DiagnosingDx, I’m joined by Wissam Hamou, Chief Operating Officer of One Biosciences, a company bringing single-cell diagnostics out of the lab and into real clinical practice.
We explore why single-cell analysis is finally ready for the clinic, how AI is unlocking insights that were previously impossible to see, and what this technology means for trials, treatment response, and the future of precision medicine.
Key Takeaways:
🔹 Single-cell technology is advancing toward real clinical validation, backed by fresh Series A funding.
🔹 AI is essential for making sense of the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.